US Stock MarketDetailed Quotes

Whitehawk Therapeutics (WHWK)

Watchlist

4.000
+0.530+15.27%

Close Apr 14 15:59 ET

3.980
-0.020-0.50%

Post 19:40 ET

188.79MMarket Cap-12.12P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Whitehawk Therapeutics (WHWK) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

-72.50%7.15M

33.48%7.15M

6.69%25.98M

14.43%7.24M

21.03%7.21M

-0.37%6.18M

-8.76%5.35M

Operating revenue

-72.50%7.15M

--0

33.48%7.15M

6.69%25.98M

14.43%7.24M

21.03%7.21M

-0.37%6.18M

-8.76%5.35M

Cost of revenue

-74.87%760K

16.56%760K

7.65%3.02M

-14.78%790K

15.35%804K

18.60%778K

23.25%652K

Gross profit

-72.19%6.39M

35.82%6.39M

6.56%22.96M

19.45%6.45M

21.78%6.41M

-2.61%5.4M

-11.93%4.7M

Operating expense

37.60%120.79M

-2.01%24.89M

13.75%19.55M

160.90%54.75M

-10.78%21.6M

-6.10%87.78M

9.89%25.4M

-25.65%17.18M

-16.36%20.99M

9.25%24.21M

Selling and administrative expenses

-18.85%29.82M

-46.92%5.87M

-27.62%5.2M

-24.73%5.94M

20.67%12.82M

-17.51%36.75M

6.82%11.05M

-35.96%7.19M

-32.98%7.89M

-5.24%10.62M

Research and development costs

78.25%90.96M

32.58%19.02M

43.49%14.35M

272.79%48.81M

-35.35%8.79M

4.29%51.03M

12.37%14.35M

-15.92%10M

-1.67%13.09M

24.07%13.59M

Operating profit

-76.49%-114.4M

-31.34%-24.89M

-81.40%-19.55M

-251.32%-54.75M

22.01%-15.22M

9.89%-64.82M

-6.97%-18.95M

39.63%-10.78M

20.27%-15.58M

-15.97%-19.51M

Net non-operating interest income expense

65.23%6.23M

138.31%1.61M

113.13%1.85M

97.31%1.98M

-35.38%791K

-38.87%3.77M

-53.15%676K

-43.89%868K

-36.40%1M

-23.60%1.22M

Non-operating interest income

58.75%6.23M

138.31%1.61M

104.19%1.85M

86.52%1.98M

-38.30%791K

-38.67%3.93M

-54.93%676K

-43.55%906K

-35.11%1.06M

-22.77%1.28M

Non-operating interest expense

--0

-33.33%154K

--0

-34.48%38K

0.00%58K

Other net income (expense)

3,414.65%87.57M

25K

98.11%-50K

7,850.00%155K

8,744,400.00%87.44M

-264,100.00%-2.64M

-2.64M

33.33%-2K

-1K

Gain on sale of security

225.00%5K

--8K

----

-50.00%-3K

----

-300.00%-4K

--0

---1K

33.33%-2K

---1K

Special income (charges)

3,408.04%87.27M

--0

93.29%-177K

--0

--87.44M

---2.64M

--0

---2.64M

--0

-Less：Restructuring and merger&acquisition

--0

----

--2.64M

--0

--2.64M

----

-Gain on sale of business

--87.27M

--0

---177K

--0

--87.44M

--0

Other non- operating income (expenses)

--302K

--17K

--127K

--158K

----

Income before tax

67.66%-20.6M

-27.24%-23.25M

-41.45%-17.75M

-260.80%-52.62M

499.23%73.02M

3.15%-63.69M

-12.32%-18.27M

23.04%-12.55M

18.85%-14.58M

-20.14%-18.29M

Income tax

Net income

67.66%-20.6M

-27.24%-23.25M

-41.45%-17.75M

-260.80%-52.62M

499.23%73.02M

3.15%-63.69M

-12.32%-18.27M

23.04%-12.55M

18.85%-14.58M

-20.14%-18.29M

Net income continuous Operations

67.66%-20.6M

-27.24%-23.25M

-41.45%-17.75M

-260.80%-52.62M

499.23%73.02M

3.15%-63.69M

-12.32%-18.27M

23.04%-12.55M

18.85%-14.58M

-20.14%-18.29M

Minority interest income

Net income attributable to the parent company

67.66%-20.6M

-27.24%-23.25M

-41.45%-17.75M

-260.80%-52.62M

499.23%73.02M

3.15%-63.69M

-12.32%-18.27M

23.04%-12.55M

18.85%-14.58M

-20.14%-18.29M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

67.66%-20.6M

-27.24%-23.25M

-41.45%-17.75M

-260.80%-52.62M

499.23%73.02M

3.15%-63.69M

-12.32%-18.27M

23.04%-12.55M

18.85%-14.58M

-20.14%-18.29M

Basic earnings per share

86.02%-0.33

49.25%-0.34

43.48%-0.26

-40.74%-0.76

370.59%1.84

3.28%-2.36

-11.67%-0.67

23.33%-0.46

19.40%-0.54

-19.30%-0.68

Diluted earnings per share

86.02%-0.33

49.25%-0.34

43.48%-0.26

-40.74%-0.76

369.12%1.83

3.28%-2.36

-11.67%-0.67

23.33%-0.46

19.40%-0.54

-19.30%-0.68

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	-72.50%7.15M	0	0	0	33.48%7.15M	6.69%25.98M	14.43%7.24M	21.03%7.21M	-0.37%6.18M	-8.76%5.35M
Operating revenue	-72.50%7.15M	--0	--0	--0	33.48%7.15M	6.69%25.98M	14.43%7.24M	21.03%7.21M	-0.37%6.18M	-8.76%5.35M
Cost of revenue	-74.87%760K	0	0	0	16.56%760K	7.65%3.02M	-14.78%790K	15.35%804K	18.60%778K	23.25%652K
Gross profit	-72.19%6.39M	0	0	0	35.82%6.39M	6.56%22.96M	19.45%6.45M	21.78%6.41M	-2.61%5.4M	-11.93%4.7M
Operating expense	37.60%120.79M	-2.01%24.89M	13.75%19.55M	160.90%54.75M	-10.78%21.6M	-6.10%87.78M	9.89%25.4M	-25.65%17.18M	-16.36%20.99M	9.25%24.21M
Selling and administrative expenses	-18.85%29.82M	-46.92%5.87M	-27.62%5.2M	-24.73%5.94M	20.67%12.82M	-17.51%36.75M	6.82%11.05M	-35.96%7.19M	-32.98%7.89M	-5.24%10.62M
Research and development costs	78.25%90.96M	32.58%19.02M	43.49%14.35M	272.79%48.81M	-35.35%8.79M	4.29%51.03M	12.37%14.35M	-15.92%10M	-1.67%13.09M	24.07%13.59M
Operating profit	-76.49%-114.4M	-31.34%-24.89M	-81.40%-19.55M	-251.32%-54.75M	22.01%-15.22M	9.89%-64.82M	-6.97%-18.95M	39.63%-10.78M	20.27%-15.58M	-15.97%-19.51M
Net non-operating interest income expense	65.23%6.23M	138.31%1.61M	113.13%1.85M	97.31%1.98M	-35.38%791K	-38.87%3.77M	-53.15%676K	-43.89%868K	-36.40%1M	-23.60%1.22M
Non-operating interest income	58.75%6.23M	138.31%1.61M	104.19%1.85M	86.52%1.98M	-38.30%791K	-38.67%3.93M	-54.93%676K	-43.55%906K	-35.11%1.06M	-22.77%1.28M
Non-operating interest expense	--0	--0	--0	--0	--0	-33.33%154K	--0	-34.48%38K	0.00%58K	0.00%58K
Other net income (expense)	3,414.65%87.57M	25K	98.11%-50K	7,850.00%155K	8,744,400.00%87.44M	-264,100.00%-2.64M	0	-2.64M	33.33%-2K	-1K
Gain on sale of security	225.00%5K	--8K	----	-50.00%-3K	----	-300.00%-4K	--0	---1K	33.33%-2K	---1K
Special income (charges)	3,408.04%87.27M	--0	93.29%-177K	--0	--87.44M	---2.64M	--0	---2.64M	--0	--0
-Less：Restructuring and merger&acquisition	--0	--0	--0	----	----	--2.64M	--0	--2.64M	----	----
-Gain on sale of business	--87.27M	--0	---177K	--0	--87.44M	--0	--0	--0	--0	--0
Other non- operating income (expenses)	--302K	--17K	--127K	--158K	----	----	----	----	----	----
Income before tax	67.66%-20.6M	-27.24%-23.25M	-41.45%-17.75M	-260.80%-52.62M	499.23%73.02M	3.15%-63.69M	-12.32%-18.27M	23.04%-12.55M	18.85%-14.58M	-20.14%-18.29M
Income tax	0					0
Net income	67.66%-20.6M	-27.24%-23.25M	-41.45%-17.75M	-260.80%-52.62M	499.23%73.02M	3.15%-63.69M	-12.32%-18.27M	23.04%-12.55M	18.85%-14.58M	-20.14%-18.29M
Net income continuous Operations	67.66%-20.6M	-27.24%-23.25M	-41.45%-17.75M	-260.80%-52.62M	499.23%73.02M	3.15%-63.69M	-12.32%-18.27M	23.04%-12.55M	18.85%-14.58M	-20.14%-18.29M
Minority interest income
Net income attributable to the parent company	67.66%-20.6M	-27.24%-23.25M	-41.45%-17.75M	-260.80%-52.62M	499.23%73.02M	3.15%-63.69M	-12.32%-18.27M	23.04%-12.55M	18.85%-14.58M	-20.14%-18.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	67.66%-20.6M	-27.24%-23.25M	-41.45%-17.75M	-260.80%-52.62M	499.23%73.02M	3.15%-63.69M	-12.32%-18.27M	23.04%-12.55M	18.85%-14.58M	-20.14%-18.29M
Basic earnings per share	86.02%-0.33	49.25%-0.34	43.48%-0.26	-40.74%-0.76	370.59%1.84	3.28%-2.36	-11.67%-0.67	23.33%-0.46	19.40%-0.54	-19.30%-0.68
Diluted earnings per share	86.02%-0.33	49.25%-0.34	43.48%-0.26	-40.74%-0.76	369.12%1.83	3.28%-2.36	-11.67%-0.67	23.33%-0.46	19.40%-0.54	-19.30%-0.68
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm